0MFU Stock Overview
Develops, produces, and distributes various analog and digital imaging systems worldwide. More details
| Snowflake Score | |
|---|---|
| Valuation | 4/6 |
| Future Growth | 4/6 |
| Past Performance | 0/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
Agfa-Gevaert NV Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | €0.67 |
| 52 Week High | €1.50 |
| 52 Week Low | €0.59 |
| Beta | 0.69 |
| 11 Month Change | -35.05% |
| 3 Month Change | -41.21% |
| 1 Year Change | -54.92% |
| 33 Year Change | -80.91% |
| 5 Year Change | -86.09% |
| Change since IPO | -91.32% |
Recent News & Updates
Recent updates
Shareholder Returns
| 0MFU | GB Healthcare Services | GB Market | |
|---|---|---|---|
| 7D | 3.9% | 3.8% | 1.7% |
| 1Y | -54.9% | 30.6% | 8.3% |
Return vs Industry: 0MFU underperformed the UK Healthcare Services industry which returned 30.6% over the past year.
Return vs Market: 0MFU underperformed the UK Market which returned 8.3% over the past year.
Price Volatility
| 0MFU volatility | |
|---|---|
| 0MFU Average Weekly Movement | 7.4% |
| Healthcare Services Industry Average Movement | 6.1% |
| Market Average Movement | 4.8% |
| 10% most volatile stocks in GB Market | 10.3% |
| 10% least volatile stocks in GB Market | 2.6% |
Stable Share Price: 0MFU's share price has been volatile over the past 3 months compared to the UK market.
Volatility Over Time: 0MFU's weekly volatility (7%) has been stable over the past year, but is still higher than 75% of UK stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1867 | 4,819 | Pascal Juery | www.agfa.com |
Agfa-Gevaert NV develops, produces, and distributes various analog and digital imaging systems worldwide. It operates through four segments: HealthCare IT, Digital Print & Chemicals, Radiology Solutions, and CONOPS. The company’s CONOPS segment engages in supply of film and chemicals, as well support services.
Agfa-Gevaert NV Fundamentals Summary
| 0MFU fundamental statistics | |
|---|---|
| Market cap | €103.73m |
| Earnings (TTM) | -€32.00m |
| Revenue (TTM) | €1.13b |
0.1x
P/S Ratio-3.2x
P/E RatioIs 0MFU overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 0MFU income statement (TTM) | |
|---|---|
| Revenue | €1.13b |
| Cost of Revenue | €774.00m |
| Gross Profit | €352.00m |
| Other Expenses | €384.00m |
| Earnings | -€32.00m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.21 |
| Gross Margin | 31.26% |
| Net Profit Margin | -2.84% |
| Debt/Equity Ratio | 0% |
How did 0MFU perform over the long term?
See historical performance and comparison